Grown Rogue International (GRUSF) Net Income towards Common Stockholders (2013 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Net Income towards Common Stockholders of -$2.7 million in Q1 2026, up 100.0% quarter-over-quarter from -$5017.9 billion in Q4 2025, and down 551.29% on a YoY basis from $598782.0 in Q1 2025.

Grown Rogue International (GRUSF) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends

Grown Rogue International's Net Income towards Common Stockholders history runs 13 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 551.29% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$2319.6 billion (down 190.48% YoY), while the FY2025 annual figure was -$452962.0, up 97.17% from the prior year.
  • Net Income towards Common Stockholders was -$2.7 million for Q1 2026 at Grown Rogue International, up from -$5017.9 billion in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2698.3 billion in Q3 2025 to a low of -$5017.9 billion in Q4 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$222.7 billion across 5 years, with a median of -$4989.0 in 2022.
  • The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders surged 437.92% in 2025, then slumped 551.29% in 2026.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$422824.0 in 2022, then jumped by 252.03% to $642820.0 in 2023, then slumped by 124220877.2% to -$798.5 billion in 2024, then slumped by 528.4% to -$5017.9 billion in 2025, then jumped by 100.0% to -$2.7 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$2.7 million (Q1 2026), -$5017.9 billion (Q4 2025), and $2698.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 366.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 1.99 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Grown Rogue International - - 3.96 Mn -2.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.70 Mn
Dec 31, 2025 -5,017.87 Bn
Sep 30, 2025 2,698.31 Bn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 598,782.00
Sep 30, 2024 -798.52 Bn
Jun 30, 2024 -5.62 Mn
Mar 31, 2024 -4.20 Mn
Dec 31, 2023 642,820.00
Oct 31, 2023 -1.47 Mn
Jul 31, 2023 640,713.00
Apr 30, 2023 412,846.00
Jan 31, 2023 931,945.00
Jan 31, 2022 -422,824.00
Jul 31, 2021 -54,533.00
Apr 30, 2021 -1.43 Mn
Jan 31, 2021 -1.08 Mn
Oct 31, 2020 26,352.00
Jul 31, 2020 -798,200.00
Apr 30, 2020 -1.28 Mn